Gladstone Institutional Advisory’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,474
| Closed | -$253K | – | 710 |
|
|
2024
Q3 | $253K | Sell |
1,474
-407
| -22% | -$70K | 0.01% | 604 |
|
|
2024
Q2 | $290K | Sell |
1,881
-702
| -27% | -$108K | 0.02% | 550 |
|
|
2024
Q1 | $397K | Sell |
2,583
-1,026
| -28% | -$158K | 0.02% | 467 |
|
|
2023
Q4 | $570K | Sell |
3,609
-1,089
| -23% | -$172K | 0.03% | 393 |
|
|
2023
Q3 | $688K | Buy |
4,698
+155
| +3% | +$22.7K | 0.04% | 335 |
|
|
2023
Q2 | $696K | Buy |
4,543
+263
| +6% | +$40.3K | 0.04% | 340 |
|
|
2023
Q1 | $664K | Sell |
4,280
-530
| -11% | -$82.2K | 0.04% | 352 |
|
|
2022
Q4 | $741K | Sell |
4,810
-9,502
| -66% | -$1.46M | 0.05% | 327 |
|
|
2022
Q3 | $1.89M | Buy |
14,312
+3,801
| +36% | +$502K | 0.15% | 176 |
|
|
2022
Q2 | $1.43M | Buy |
10,511
+5,036
| +92% | +$683K | 0.11% | 211 |
|
|
2022
Q1 | $817K | Sell |
5,475
-10,758
| -66% | -$1.61M | 0.06% | 337 |
|
|
2021
Q4 | $2.63M | Buy |
16,233
+376
| +2% | +$60.9K | 0.2% | 135 |
|
|
2021
Q3 | $2.63M | Buy |
15,857
+514
| +3% | +$85.3K | 0.26% | 110 |
|
|
2021
Q2 | $2.65M | Buy |
15,343
+1,935
| +14% | +$334K | 0.31% | 84 |
|
|
2021
Q1 | $2.15M | Buy |
13,408
+6,589
| +97% | +$1.06M | 0.33% | 73 |
|
|
2020
Q4 | $1.15M | Buy |
+6,819
| New | +$1.15M | 0.23% | 98 |
|
|
2020
Q3 | – | Sell |
-7,942
| Closed | -$1.33M | – | 281 |
|
|
2020
Q2 | $1.33M | Buy |
7,942
+5,902
| +289% | +$990K | 0.34% | 69 |
|
|
2020
Q1 | $267K | Buy |
2,040
+509
| +33% | +$66.6K | 0.07% | 208 |
|
|
2019
Q4 | $228K | Buy |
+1,531
| New | +$228K | 0.06% | 237 |
|